A randomized, open-label, active-controlled multi-center study to evaluate the safety of rivaroxaban and vitamin K antagonists in subjects undergoing catheter ablation for atrial fibrillation (VENTURE-AF)
Clinical Trial Grant
Administered By
Institutes and Centers
Awarded By
Janssen Scientific Affairs, LLC.
Start Date
November 28, 2013
End Date
May 12, 2015
Administered By
Institutes and Centers
Awarded By
Janssen Scientific Affairs, LLC.
Start Date
November 28, 2013
End Date
May 12, 2015